| 2006 |
Loss-of-function UNC93B1 mutations in humans result in impaired cellular IFN-α/β and IFN-λ antiviral responses, establishing UNC93B1 as essential for TLR3/7/9-dependent antiviral signaling in vivo. |
Human genetic study; functional assays in patient cells (interferon response measurements) |
Science |
High |
16973841
|
| 2006 |
A missense mutation (H412R) in Unc93b1 ('3d' mutation) abolishes signaling through intracellular TLR3, TLR7, and TLR9, and also impairs cross-presentation and MHC class II presentation of exogenous antigen; UNC93B1 was identified as a 12-transmembrane-spanning ER-resident protein. |
ENU mutagenesis screen; positional cloning; functional TLR signaling assays; antigen presentation assays in dendritic cells |
Nature immunology |
High |
16415873
|
| 2008 |
UNC93B1 physically interacts with TLR7 and TLR9 in the ER and delivers them to endolysosomes; the H412R mutation prevents TLR binding and blocks ER exit of TLR7 and TLR9, while wild-type UNC93B1 rescues trafficking and signaling defects in 3d dendritic cells. |
Co-immunoprecipitation; subcellular fractionation; live-cell imaging; genetic complementation in 3d dendritic cells |
Nature |
High |
18305481
|
| 2009 |
UNC93B1 residue D34 represses TLR7-mediated responses while favoring TLR9; D34A mutation increases Unc93B1 association with TLR7 and ligand-induced TLR7 trafficking while decreasing TLR9 association and trafficking, biasing nucleic acid sensing toward DNA-sensing in dendritic cells. |
Complementation cloning; co-immunoprecipitation; endolysosomal trafficking assays; TLR signaling assays with TLR-specific ligands |
The Journal of experimental medicine |
High |
19451267
|
| 2010 |
UNC93B1 interacts directly with TLR11 in the ER and is required for TLR11-dependent IL-12 secretion and dendritic cell activation in response to Toxoplasma gondii profilin, demonstrating that UNC93B1 interaction and intracellular localization are not unique to nucleic acid-sensing TLRs. |
Co-immunoprecipitation; subcellular localization; IL-12 secretion assays; in vivo infection model with UNC93B1-deficient mice |
The Journal of biological chemistry |
High |
21097503
|
| 2011 |
TLR9 competes with TLR7 for UNC93B1-dependent trafficking and predominates; a D34A mutation in UNC93B1 reverses this balance toward TLR7, causing TLR7-dependent systemic lethal inflammation in mice driven by CD4+ T cell Th1/Th17 differentiation and B cell activity. |
Knock-in mouse model (D34A); TLR competition assays; flow cytometry; B cell depletion experiments |
Immunity |
High |
21683627
|
| 2013 |
UNC93B1 enters the secretory pathway and directly controls packaging of TLRs into COPII vesicles budding from the ER; it remains associated with TLRs through post-Golgi sorting. TLR9 requires UNC93B1-mediated AP-2 recruitment for endolysosomal delivery, while TLR7, TLR11, TLR12, and TLR13 use alternative trafficking pathways. |
COPII vesicle budding assays; co-immunoprecipitation; AP complex interaction assays; subcellular trafficking analysis |
eLife |
High |
23426999
|
| 2013 |
Acidic residues D812/E813 of TLR9 and D699/E704 of TLR3 in the juxtamembrane region are required for UNC93B1 binding; mutation of these residues prevents UNC93B1 interaction, impairs TLR trafficking from the ER, and abolishes TLR signaling. |
Site-directed mutagenesis of TLR juxtamembrane residues; co-immunoprecipitation; subcellular localization; signaling assays |
Journal of immunology |
High |
23585677
|
| 2014 |
UNC93B1 is essential for plasma membrane localization and signaling of TLR5 (a flagellin receptor); TLR5 physically interacts with UNC93B1, and cells from 3d or UNC93B1-deficient mice lack TLR5 at the plasma membrane and fail to produce cytokines upon flagellin stimulation. |
Co-immunoprecipitation; cell surface localization assays; cytokine secretion and costimulatory molecule upregulation in 3d and UNC93B1-KO cells |
Proceedings of the National Academy of Sciences of the United States of America |
High |
24778236
|
| 2014 |
A C-terminal tyrosine-based sorting motif (YxxΦ) in UNC93B1 differentially regulates TLR7, TLR8, and TLR9 activity toward nucleic acid ligands in human B cells and monocytes; destruction of YxxΦ abolishes these TLR responses. YxxΦ controls UNC93B1 subcellular localization via both AP1- and AP2-dependent pathways, but loss of AP function does not recapitulate altered TLR responses, indicating AP-independent functions. |
Site-directed mutagenesis of UNC93B1 YxxΦ motif; TLR signaling assays in human primary cells; AP complex knockdown; subcellular localization imaging |
Journal of immunology |
High |
25187660
|
| 2011 |
UNC93B1 physically associates with human TLR8 and is required for TLR8-mediated signaling; TLR8 localizes to early endosomes and ER but not late endosomes or lysosomes, and the transmembrane domain and TIR domain of TLR8 are required for proper early endosomal targeting. |
Co-immunoprecipitation; subcellular localization (confocal microscopy with organelle markers); TLR8 signaling assays; truncation mutant analysis |
PloS one |
Medium |
22164301
|
| 2015 |
LRRC59, an ER membrane protein, associates with UNC93B1 upon ligand stimulation (in a TLR-independent manner requiring signals from ligand internalization) and promotes UNC93B1-mediated translocation of TLR3, TLR8, and TLR9 from the ER to endosomes. |
Co-immunoprecipitation (ligand-induced); siRNA knockdown of LRRC59; subcellular localization of endogenous TLR3; TLR signaling assays |
Journal of immunology |
Medium |
26466955
|
| 2017 |
UNC93B1 interacts with the ER calcium sensor STIM1, and this interaction is required for STIM1 oligomerization and activation; UNC93B1 deficiency impairs endosomal acidification, phagosomal maturation, antigen degradation, antigen export to the cytosol, and STIM1 function, resulting in compromised antigen cross-presentation. Expression of a constitutively active STIM1 mutant that does not bind UNC93B1 restores antigen degradation and cross-presentation in 3d-mutated DCs. |
Co-immunoprecipitation (UNC93B1-STIM1); constitutively active STIM1 mutant rescue; antigen cross-presentation assays; calcium flux measurements in 3d DCs |
Nature communications |
High |
29158474
|
| 2018 |
UNC93B1 deficiency causes near-complete loss of TLR3 and TLR7 proteins in primary dendritic cells and macrophages, demonstrating that UNC93B1 is critical for TLR protein stability upstream of trafficking; expression of an ER-retained UNC93B1 version is sufficient to stabilize TLRs and largely restore endosomal TLR trafficking and activity. |
Western blot of TLR protein levels in UNC93B1-KO vs WT primary cells; ER-retained UNC93B1 mutant rescue experiments; TLR signaling assays |
Immunity |
High |
29768176
|
| 2019 |
UNC93B1 specifically limits TLR7 (but not TLR9) signaling by recruiting syntenin-1; UNC93B1 mutations that enhance TLR7 signaling disrupt syntenin-1 binding. UNC93B1 and TLR7 are detectable in exosomes, suggesting UNC93B1-syntenin-1 interaction facilitates sorting of TLR7 into intralumenal vesicles of multivesicular bodies to terminate signaling. Phosphorylation of UNC93B1 is required for syntenin-1 binding. |
Co-immunoprecipitation; exosome fractionation and Western blot; mutagenesis; phosphorylation analysis; TLR7-specific autoimmunity in knock-in mice |
Nature |
High |
31546246
|
| 2019 |
TLR9 (and TLR3) are released from UNC93B1 within endosomes, and this release is required for ligand binding and signal transduction; UNC93B1 mutations that increase TLR9 affinity or an artificial tether preventing release block TLR9 signaling. TLR7 does not dissociate from UNC93B1 in endosomes and is regulated by distinct mechanisms. |
Co-immunoprecipitation at different pH/compartments; tethered UNC93B1-TLR9 fusion constructs; affinity-increasing mutations; TLR signaling assays |
Nature |
High |
31546247
|
| 2021 |
Cryo-EM structures of human and mouse TLR3-UNC93B1 complexes and human TLR7-UNC93B1 complex reveal that UNC93B1 exhibits structural similarity to major facilitator superfamily transporters; both TLRs interact with the UNC93B1 N-terminal six-helix bundle through their transmembrane and luminal juxtamembrane regions; TLR3 and TLR7 complexes differ in their oligomerization state. |
Cryo-electron microscopy structural determination |
Nature structural & molecular biology |
High |
33432245
|
| 2022 |
N-glycosylation of UNC93B1 at Asn272 (but not Asn251) is required for TLR9 signaling; the N272Q mutation selectively impairs MyD88 recruitment to TLR9 and downstream signaling without affecting TLR7 signaling, UNC93B1 expression, or TLR9 localization. The two N-glycosylation sites (Asn251 and Asn272) can be glycosylated independently. |
Site-directed mutagenesis (N251Q, N272Q); TLR9 signaling assays; co-immunoprecipitation of MyD88-TLR9; subcellular localization; TLR7 signaling comparison |
Frontiers in immunology |
High |
35874766
|
| 2022 |
UNC93B1 attenuates cGAS-STING signaling by directly interacting with STING and delivering it to lysosomes for autophagy-dependent degradation; UNC93B1 knockout enhances STING-dependent IFN-β production and reduces STING protein degradation. This function depends on UNC93B1 trafficking capability. |
Co-immunoprecipitation (UNC93B1-STING); UNC93B1 overexpression and knockout; lysosome inhibitor rescue; IFN-β promoter assays; IRF3 nuclear translocation; HSV-1 infection in KO mice |
Journal of medical virology |
Medium |
35577759
|
| 2021 |
UNC93B1 directly interacts with STING and promotes STING protein degradation; UNC93B1 deficiency blunts TLR3 signaling but augments innate immune responses to cytosolic DNA stimulation by causing STING accumulation, demonstrating a negative regulatory role on STING-mediated signaling. |
Co-immunoprecipitation (UNC93B1-STING); UNC93B1 knockdown/KO; cytosolic DNA stimulation assays; STING protein level measurement |
European journal of immunology |
Medium |
33837956
|
| 2022 |
UNC93B1 interacts with STIM1 in the ER lumen near the transmembrane domain; UNC93B1 binding promotes zipping of transmembrane and proximal cytosolic helices within resting STIM1 dimers, priming them for translocation. UNC93B1 deficiency reduces store-operated Ca2+ entry, STIM1-Orai1 interactions, and targets STIM1 to lighter ER domains; UNC93B1 expression accelerates STIM1 recruitment to cortical ER domains. |
Co-immunoprecipitation; cysteine crosslinking in vivo; calcium flux measurements; STIM1-Orai1 Co-IP; subcellular fractionation; live-cell imaging |
The Journal of biological chemistry |
High |
35065962
|
| 2012 |
UNC93B1 promotes trafficking of differentially glycosylated TLR3 (but not other NA-sensing TLRs) to the plasma membrane in human epithelial cells; poly(I:C) up-regulates UNC93B1 transcription via TLR3 activation; UNC93B1 increases protein lifetime of TLR3 and TLR9 and augments signaling of all NA-sensing TLRs. Poly(I:C) pretreatment primes B cells to ssDNA activation via UNC93B1 up-regulation. |
siRNA knockdown; confocal microscopy for TLR3 localization; Western blot for protein stability; TLR signaling assays; UNC93B1 promoter analysis |
The Journal of biological chemistry |
Medium |
23166319
|
| 2003 |
In C. elegans, UNC-93 colocalizes with SUP-9 (a two-pore K+ channel) and SUP-10 within muscle cells, and genetic evidence suggests these three proteins form a multisubunit complex coordinating muscle contraction; UNC-93 defines a novel multigene family conserved in C. elegans, Drosophila, and humans. |
Genetic epistasis analysis; cloning of sup-9 and sup-10; colocalization by immunofluorescence in muscle cells |
The Journal of neuroscience |
Low |
14534247
|
| 2024 |
UNC93B1 variants E92G and R336L cause selective TLR7 hyperactivation; E92G causes UNC93B1 protein instability and reduced interaction with TLR7, leading to constitutive type I IFN signaling, while neither variant affects TLR3 or TLR9 responses, establishing UNC93B1 as a TLR subtype-specific regulator. |
Patient cell functional assays; mouse macrophage model with variants; co-immunoprecipitation (UNC93B1-TLR7); cytokine measurements; protein stability assays |
Science immunology |
High |
38207055
|
| 2024 |
UNC93B1 variants I317M, G325C cause gain of TLR7 and TLR8 activity in SLE patients; variants L330R, R466S, R525P cause gain of TLR8 activity in chilblain lupus patients. G325C, L330R, and R466S variants show enhanced interaction with TLR8 by Co-IP, while R525P does not, indicating different disease mechanisms for different mutations. |
In vitro TLR signaling assays; ex vivo patient cell assays; co-immunoprecipitation (UNC93B1 variants with TLR8) |
The Journal of experimental medicine |
High |
38869500
|
| 2024 |
Systematic alanine scanning mutagenesis of all cytosolic and luminal UNC93B1 residues identified distinct positive and negative regulatory regions for TLR3, TLR7, and TLR9 responses; human variants UNC93B1-T93I and UNC93B1-R336C in identified negative regulatory regions enhance TLR7/8 responses and cause systemic autoimmune disease when introduced into mice. |
Scanning alanine mutagenesis screen; TLR signaling assays (TLR3, TLR7/8, TLR9); CRISPR knock-in mouse models; patient variant analysis |
The Journal of experimental medicine |
High |
38780621
|
| 2024 |
UNC93B1 variant V117L is associated with increased TLR7/8 (but not TLR3/TLR9) responses; variant T314A (proximal to TLR7 transmembrane domain) also causes exaggerated TLR7/8 responses; heterozygous mice expressing Unc93b1 V117L develop spontaneous lupus-like disease. |
Patient cell functional assays; THP-1 cell TLR stimulation assays; heterozygous knock-in mouse model; cytokine and IFN measurements |
Nature immunology |
High |
38831104
|
| 2021 |
UNC93B1 is expressed in multiple CNS cell types (microglia, astrocytes, oligodendrocytes, neurons) and is required for microglial activation and neuronal injury induced by extracellular let-7b (a TLR7 activator); intrathecal let-7b causes neurodegeneration in wild-type but not UNC93B1-deficient mice. |
PCR, immunocytochemistry, flow cytometry for expression; TNF ELISA in UNC93B1-deficient microglia; neuronal injury assays in vitro; intrathecal injection in vivo; neurodegeneration assessment |
Frontiers in immunology |
Medium |
34589086
|
| 2025 |
PANK4 interacts with UNC93B1 to suppress TLR7 and TLR9-mediated cytokine responses, acting as a negative regulator of nucleic acid-sensing innate immune pathways. |
Co-immunoprecipitation (PANK4-UNC93B1); TLR7/9 signaling assays with PANK4 loss-of-function |
bioRxivpreprint |
Low |
|